Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes

Rachel Cusatis; Heather R Tecca; Anita D’Souza; Bronwen E Shaw; Kathryn E. Flynn

doi:10.1002/cncr.32808

Publisher Website

Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes

Authors

Cusatis, Rachel¹
Tecca, Heather R²
D’Souza, Anita¹
Shaw, Bronwen E¹
Flynn, Kathryn E.¹

¹ Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA
² Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA

Type

Published Article

Journal

Cancer

Publisher

Wiley (John Wiley & Sons)

Publication Date

Mar 10, 2020

Volume

126

Issue

11

Pages

2679–2686

Identifiers

DOI: 10.1002/cncr.32808

PMID: 32154926

PMCID: PMC7220834

Source

PubMed Central

Keywords

License

Unknown

Abstract

Among patients who underwent allogenic HCT and lived to at least 100 days, most did not report regretting their transplant, though 15% did within 1 year. Relapse significantly increased the risk of reporting regret while baseline social well-being significantly decreased the risk of regret.

Report this publication

Statistics

Seen <100 times